{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:24:14Z","timestamp":1789961054342,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bioorg.2025.108181","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:24:09Z","timestamp":1737545049000},"page":"108181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Exploration of anti-inflammatory activity of pyrazolo[3,4-d]pyrimidine\/1,2,4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: Design, synthesis, in silico and in vivo studies"],"prefix":"10.1016","volume":"156","author":[{"given":"Marwa A.","family":"Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Al-Awadh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman S.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deiaa E.","family":"Elsayed Abouzed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal El-Din A.","family":"Abuo-Rahma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouh F.A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108181_b0005","article-title":"Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells","volume":"13","author":"Jin","year":"2023","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108181_b0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1742-1241.2007.01320.x","article-title":"Zileuton: clinical implications of 5\u2010Lipoxygenase inhibition in severe airway disease","volume":"61","author":"Berger","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bioorg.2025.108181_b0015","doi-asserted-by":"crossref","unstructured":"M.G. Kim, S. Kim, K.-H. Boo, J.-H. Kim, C.S. Kim, Anti-inflammatory effects of immature Citrus unshiu fruit extracts via suppression of NF-\u03baB and MAPK signal pathways in LPS-induced RAW264. 7 macrophage cells, Food Sci. Biotechnol. 33(4) (2024) 903-911. https:\/\/doi.org\/10.1007\/s10068-023-01390-2.","DOI":"10.1007\/s10068-023-01390-2"},{"key":"10.1016\/j.bioorg.2025.108181_b0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.abb.2016.04.011","article-title":"Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGES-1","volume":"603","author":"Akasaka","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"issue":"44","key":"10.1016\/j.bioorg.2025.108181_b0025","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1093\/eurheartj\/ehx533","article-title":"Safety of non-steroidal anti-inflammatory drugs","volume":"38","author":"Weintraub","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bioorg.2025.108181_b0030","first-page":"1737","article-title":"Introduction to COX inhibitors","author":"Biava","year":"2018","journal-title":"Future Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108181_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9343(00)00728-2","article-title":"Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2\u2013specific inhibitors","volume":"110","author":"Buttgereit","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bioorg.2025.108181_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.003","article-title":"Acute kidney injury associated with non-steroidal anti-inflammatory drugs","volume":"101","author":"Klomjit","year":"2022","journal-title":"Eur. J. Intern. Med."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108181_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.3025","article-title":"Synthesis of new compounds bearing methyl sulfonyl pharmacophore as selective COX\u20102 inhibitor","volume":"36","author":"Almarsoomi","year":"2023","journal-title":"J. Mol. Recognit."},{"issue":"15","key":"10.1016\/j.bioorg.2025.108181_b0050","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehr421","article-title":"Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib","volume":"33","author":"B\u00e4ck","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bioorg.2025.108181_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103878","article-title":"Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold","volume":"100","author":"Ibrahim","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108181_b0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bioorg.2019.02.043","article-title":"Novel aryl carboximidamide and 3-aryl-1, 2, 4-oxadiazole analogues of naproxen as dual selective COX-2\/15-LOX inhibitors: Design, synthesis and docking studies","volume":"85","author":"Youssif","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108181_b0065","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.3390\/molecules28145479","article-title":"Synthesis, Biological, Spectroscopic and Computational Investigations of Novel N-Acylhydrazone Derivatives of Pyrrolo [3, 4-d] pyridazinone as Dual COX\/LOX Inhibitors","volume":"28","author":"Mikus","year":"2023","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.bioorg.2025.108181_b0070","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.3390\/molecules28135085","article-title":"S-Ethyl-Isothiocitrullin-Based Dipeptides and 1, 2, 4-Oxadiazole Pseudo-Dipeptides: Solid Phase Synthesis and Evaluation as NO Synthase Inhibitors","volume":"28","author":"Mauchauff\u00e9e","year":"2023","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108181_b0075","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1021\/acs.jmedchem.9b00039","article-title":"Novel pyrazolo [4, 3-d] pyrimidine as potent and orally active inducible nitric oxide synthase (iNOS) dimerization inhibitor with efficacy in rheumatoid arthritis mouse model","volume":"62","author":"Shi","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108181_b0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1872213X11307020004","article-title":"Developments in synthesis of the anti-inflammatory drug, celecoxib: a review","volume":"7","author":"Kumar","year":"2013","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108181_b0085","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2019.03.052","article-title":"New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES","volume":"171","author":"Hassan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108181_b0090","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bioorg.2018.03.030","article-title":"Design, synthesis and evaluation of some pyrazolo [3, 4-d] pyrimidines as anti-inflammatory agents","volume":"78","author":"Tageldin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108181_b0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bioorg.2019.02.014","article-title":"Anti-inflammatory drug approach: synthesis and biological evaluation of novel pyrazolo [3, 4-d] pyrimidine compounds","volume":"86","author":"Atatreh","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108181_b0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.14348\/molcells.2021.0074","article-title":"A novel pyrazolo [3, 4-d] pyrimidine induces heme oxygenase-1 and exerts anti-inflammatory and neuroprotective effects","volume":"45","author":"Lee","year":"2022","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bioorg.2025.108181_b0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bioorg.2018.06.013","article-title":"Design, synthesis and evaluation of some pyrazolo [3, 4-d] pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents","volume":"80","author":"Tageldin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108181_b0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bioorg.2016.05.001","article-title":"Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents","volume":"66","author":"Rahmouni","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108181_b0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejps.2014.05.025","article-title":"Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents","volume":"62","author":"Abdelazeem","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.108181_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104439","article-title":"Design, synthesis and molecular modeling of novel aryl carboximidamides and 3-aryl-1, 2, 4-oxadiazoles derived from indomethacin as potent anti-inflammatory iNOS\/PGE2 inhibitors","volume":"105","author":"Mohamed","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108181_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0223-5234(00)01191-0","article-title":"Antihyperglycemic activity of new 1, 2, 4-oxadiazolidine-3, 5-diones","volume":"36","author":"Malamas","year":"2001","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108181_b0130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/1389557514666140329200745","article-title":"[1, 2, 4]-oxadiazoles: Synthesis and biological applications","volume":"14","author":"Bora","year":"2014","journal-title":"Mini Rev. Med. Chem."},{"issue":"37","key":"10.1016\/j.bioorg.2025.108181_b0135","doi-asserted-by":"crossref","first-page":"10305","DOI":"10.1002\/slct.201801558","article-title":"Design, Synthesis and Biological Evaluation of 2 (((5\u2010aryl\u20101, 2, 4\u2010oxadiazol\u20103\u2010yl) methyl) thio) benzo [d] oxazoles: New Antiinflammatory and Antioxidant Agents","volume":"3","author":"Yatam","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.108181_b0140","doi-asserted-by":"crossref","unstructured":"E. Zayed, A. Elbannany, S. Ghozlan, Activated nitriles in heterocyclic synthesis. Novel synthesis of pyrazoles, pyridones and pyrrolo [2.3-b] pyridones, Org. Prep. Proced. Int. 17(1) (1985) 70-75. https:\/\/doi.org\/10.1080\/00304948509355475.","DOI":"10.1080\/00304948509355475"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108181_b0145","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/slct.201802919","article-title":"FeCl3\/PVP as Green Homogeneous Catalyst to Synthesize 5\u2010Amino\u20101H\u2010Pyrazole\u20104\u2010Carbonitriles from Malononitrile Derivatives","volume":"4","author":"Elnagdy","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.108181_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104352","article-title":"Design and synthesis of novel pyrazolo [3, 4-d] pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy","volume":"105","author":"Ibrahim","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108181_b0155","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1134\/S1068162020050106","article-title":"Ultrasonic-assisted synthesis of pyrazolo [3, 4-d] pyrimidin-4-ol tethered with 1, 2, 3-triazoles and their anticancer activity, uss","volume":"46","author":"Kalavadiya","year":"2020","journal-title":"J. Bioorg. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2025.108181_b0160","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1016\/j.bmc.2013.07.027","article-title":"Medicinal attributes of pyrazolo [3, 4-d] pyrimidines: a review","volume":"21","author":"Chauhan","year":"2013","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108181_b0165","first-page":"515","article-title":"Use of oximes, hydroxamic acids and related species as reagents in inorganic analytical chemistry","volume":"1","author":"Ponikvar","year":"2009","journal-title":"The Chemistry of Hydroxylamines, Oximes and Hydroxamic Acids"},{"key":"10.1016\/j.bioorg.2025.108181_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00225","article-title":"Cyclooxygenase (COX)-2 inhibitors reduce Toxoplasma gondii infection and upregulate the pro-inflammatory immune response in Calomys callosus rodents and human monocyte cell line","volume":"10","author":"Pereira","year":"2019","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108181_b0175","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3390\/ijms21062237","article-title":"Analysis of the activity and expression of cyclooxygenases COX1 and COX2 in THP-1 monocytes and macrophages cultured with BiodentineTM silicate cement","volume":"21","author":"Barczak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108181_b0180","first-page":"331","article-title":"5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease, Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of","volume":"1851","author":"R\u00e5dmark","year":"2015","journal-title":"Lipids"},{"key":"10.1016\/j.bioorg.2025.108181_b0185","doi-asserted-by":"crossref","first-page":"12906","DOI":"10.3390\/ijms232112906","article-title":"The Role of Inflammation in Cardiovascular Disease","volume":"23","author":"Henein","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108181_b0190","doi-asserted-by":"crossref","first-page":"e02327","DOI":"10.1128\/spectrum.02327-21","article-title":"Nitrite promotes ROS production to potentiate cefoperazone-sulbactam-mediated elimination to lab-evolved and clinical-evolved Pseudomonas aeruginosa","volume":"10","author":"Kuang","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108181_b0195","first-page":"9","article-title":"High C-Reactive Protein Serum Levels as a Risk Factor for Preeclampsia","volume":"6","author":"Kusuma","year":"2024","journal-title":"Eur. J. Health Sci."},{"key":"10.1016\/j.bioorg.2025.108181_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109771","article-title":"Morin post-treatment surpassed calpeptin in ameliorating 3-NP-induced cortical neurotoxicity via modulation of glutamate\/calpain axis, Kidins220, and BDNF\/TrkB\/AKT\/CREB trajectory","volume":"116","author":"Mohamed","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"18","key":"10.1016\/j.bioorg.2025.108181_b0205","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.3390\/ijms20184367","article-title":"Animal models of inflammation for screening of anti-inflammatory drugs: implications for the discovery and development of phytopharmaceuticals","volume":"20","author":"Patil","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108181_b0210","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1504929","article-title":"Sanguinarine-chelerythrine fraction of coptis chinensis exerts anti-inflammatory activity in carrageenan paw oedema test in rats and reveals reduced gastrotoxicity","author":"Danielewski","year":"2022","journal-title":"Oxid. Med. Cell. Long"},{"issue":"6460","key":"10.1016\/j.bioorg.2025.108181_b0215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/367243a0","article-title":"The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1","volume":"367","author":"Picot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108181_b0220","doi-asserted-by":"crossref","unstructured":"J.L. Wang, D. Limburg, M.J. Graneto, J. Springer, J.R.B. Hamper, S. Liao, J.L. Pawlitz, R.G. Kurumbail, T. Maziasz, J.J. Talley, The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life, Bioorg. Med. Chem. Lett. 20(23) (2010) 7159-7163. https:\/\/doi.org\/10.1016\/j.bmcl.2010.07.054.","DOI":"10.1016\/j.bmcl.2010.07.054"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108181_b0225","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41589-020-0544-7","article-title":"Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products","volume":"16","author":"Gilbert","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108181_b0230","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstrom","year":"2011","journal-title":"Chem. Rev."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108181_b0235","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1073\/pnas.83.12.4175","article-title":"Characterization of leukotriene A4 synthase from murine mast cells: evidence for its identity to arachidonate 5-lipoxygenase","volume":"83","author":"Shimizu","year":"1986","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5837","key":"10.1016\/j.bioorg.2025.108181_b0240","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.1144346","article-title":"Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein","volume":"317","author":"Ferguson","year":"2007","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108181_b0245","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/13543776.2017.1276568","article-title":"Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents","volume":"27","author":"Werz","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108181_b0250","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.chembiol.2007.04.007","article-title":"Control of oxygenation in lipoxygenase and cyclooxygenase catalysis","volume":"14","author":"Schneider","year":"2007","journal-title":"Chem. Biol."},{"issue":"46","key":"10.1016\/j.bioorg.2025.108181_b0255","doi-asserted-by":"crossref","first-page":"31905","DOI":"10.1074\/jbc.M114.599662","article-title":"Crystal structure of a lipoxygenase in complex with substrate","volume":"289","author":"Neau","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108181_b0270","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108181_b0275","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/foods10061383","article-title":"Antioxidant and anti-Inflammatory effects of Zingiber officinale roscoe and Allium subhirsutum: In silico, biochemical and histological Study","volume":"10","author":"Zammel","year":"2021","journal-title":"Foods"},{"key":"10.1016\/j.bioorg.2025.108181_b0285","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11259-007-3551-1","article-title":"Elevated Plasma Levels of Interleukin 1\u03b2, Tumour Necrosis Factor \u03b1 and Monocyte Chemotactic Protein 1 Are Associated with Pregnancy Toxaemia in Ewes","volume":"31","author":"Yar\u0131m","year":"2007","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.bioorg.2025.108181_b0290","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s10753-014-9994-y","article-title":"Naringin attenuates the development of carrageenan-induced acute lung inflammation through inhibition of NF-\u03bab, STAT3 and pro-inflammatory mediators and enhancement of I\u03baB\u03b1 and anti-inflammatory cytokines","volume":"38","author":"Ahmad","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.bioorg.2025.108181_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-017-1771-7","article-title":"Evaluation of anti-inflammatory and gastric anti-ulcer activity of Phyllanthus niruri L.(Euphorbiaceae) leaves in experimental rats","volume":"17","author":"Mostofa","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"issue":"45","key":"10.1016\/j.bioorg.2025.108181_b0300","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108181_b0305","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.3390\/ijms25168588","article-title":"Correlation between Molecular Docking and the Stabilizing Interaction of HOMO-LUMO: Spirostans in CHK1 and CHK2, an In Silico Cancer Approach","volume":"25","author":"Rosales-L\u00f3pez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108181_b0310","unstructured":"Schr\u00f6dinger Release, 2: Protein preparation wizard, epik, schr\u00f6dinger, llc, new york, ny, 2021, Impact, Schr\u00f6dinger, LLC, New York, NY (2021)."},{"key":"10.1016\/j.bioorg.2025.108181_b0315","series-title":"Molecular Modeling of Proteins","first-page":"445","article-title":"Molecular Docking to Flexible Targets","author":"S\u00f8rensen","year":"2015"},{"key":"10.1016\/j.bioorg.2025.108181_b0320","unstructured":"Schr\u00f6dinger Release, 3: Desmond molecular dynamics system, DE Shaw research, New York, NY, 2017, Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, NY (2017)."},{"key":"10.1016\/j.bioorg.2025.108181_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105709","article-title":"Design, synthesis, molecular docking and molecular dynamics studies of novel triazolothiadiazine derivatives containing furan or thiophene rings as anticancer agents","volume":"122","author":"Osmaniye","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108181_b0330","first-page":"3234","article-title":"Remarks on \u2018\u2018Constant-temperature molecular dynamics with momentum conservation\u2019\u2019","volume":"50","author":"Martyna","year":"1994","journal-title":"PhysRevE"},{"key":"10.1016\/j.bioorg.2025.108181_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40203-021-00113-x","article-title":"Computational identification of 2, 4-disubstituted amino-pyrimidines as L858R\/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation DFT Study and Molecular Dynamic Simulation","volume":"9","author":"Pawara","year":"2021","journal-title":"Silico Pharmacol."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108181_b0340","doi-asserted-by":"crossref","first-page":"10693","DOI":"10.3390\/ijms221910693","article-title":"Tomatidine and patchouli alcohol as inhibitors of SARS-CoV-2 enzymes (3CLpro, PLpro and NSP15) by molecular docking and molecular dynamics simulations","volume":"22","author":"Zrieq","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T02:00:12Z","timestamp":1758852012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825000616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":65,"alternative-id":["S0045206825000616"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108181","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of anti-inflammatory activity of pyrazolo[3,4-d]pyrimidine\/1,2,4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: Design, synthesis, in silico and in vivo studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108181"}}